Evidence map›Paper›PMID 34629814›Full record

ArticleWorld journal of gastroenterology2021

Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging.

Róbert Stollmayer, Bettina K Budai, Ambrus Tóth, Ildikó Kalina, Erika Hartmann, Péter Szoldán, Viktor Bérczi, Pál Maurovich-Horvat, Pál N Kaposi

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Róbert StollmayerDepartment of Radiology, Medical Imaging Centre, Faculty of Medicine, Semmelweis University, Budapest 1083, Hungary.
Bettina K BudaiDepartment of Radiology, Medical Imaging Centre, Faculty of Medicine, Semmelweis University, Budapest 1083, Hungary. budai.bettina@med.semmelweis-univ.hu.
Ambrus TóthDepartment of Radiology, Medical Imaging Centre, Faculty of Medicine, Semmelweis University, Budapest 1083, Hungary.
Ildikó KalinaDepartment of Radiology, Medical Imaging Centre, Faculty of Medicine, Semmelweis University, Budapest 1083, Hungary.
Erika HartmannDepartment of Transplantation and Surgery, Faculty of Medicine, Semmelweis University, Budapest 1082, Hungary.
Péter SzoldánMedInnoScan Research and Development Ltd., Budapest 1112, Hungary.
Viktor BércziDepartment of Radiology, Medical Imaging Centre, Faculty of Medicine, Semmelweis University, Budapest 1083, Hungary.
Pál Maurovich-HorvatDepartment of Radiology, Medical Imaging Centre, Faculty of Medicine, Semmelweis University, Budapest 1083, Hungary.
Pál N KaposiDepartment of Radiology, Medical Imaging Centre, Faculty of Medicine, Semmelweis University, Budapest 1083, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe nature of input data is an essential factor when training neural networks. Research concerning magnetic resonance imaging (MRI)-based diagnosis of liver tumors using deep learning has been rapidly advancing. Still, evidence to support the utilization of multi-dimensional and multi-parametric image data is lacking. Due to higher information content, three-dimensional input should presumably result in higher classification precision. Also, the differentiation between focal liver lesions (FLLs) can only be plausible with simultaneous analysis of multi-sequence MRI images.

aimTo compare diagnostic efficiency of two-dimensional (2D) and three-dimensional (3D)-densely connected convolutional neural networks (DenseNet) for FLLs on multi-sequence MRI.

methodsWe retrospectively collected T2-weighted, gadoxetate disodium-enhanced arterial phase, portal venous phase, and hepatobiliary phase MRI scans from patients with focal nodular hyperplasia (FNH), hepatocellular carcinomas (HCC) or liver metastases (MET). Our search identified 71 FNH, 69 HCC and 76 MET. After volume registration, the same three most representative axial slices from all sequences were combined into four-channel images to train the 2D-DenseNet264 network. Identical bounding boxes were selected on all scans and stacked into 4D volumes to train the 3D-DenseNet264 model. The test set consisted of 10-10-10 tumors. The performance of the models was compared using area under the receiver operating characteristic curve (AUROC), specificity, sensitivity, positive predictive values (PPV), negative predictive values (NPV), and f1 scores.

resultsThe average AUC value of the 2D model (0.98) was slightly higher than that of the 3D model (0.94). Mean PPV, sensitivity, NPV, specificity and f1 scores (0.94, 0.93, 0.97, 0.97, and 0.93) of the 2D model were also superior to metrics of the 3D model (0.84, 0.83, 0.92, 0.92, and 0.83). The classification metrics of FNH were 0.91, 1.00, 1.00, 0.95, and 0.95 using the 2D and 0.90, 0.90, 0.95, 0.95, and 0.90 using the 3D models. The 2D and 3D networks' performance in the diagnosis of HCC were 1.00, 0.80, 0.91, 1.00, and 0.89 and 0.88, 0.70, 0.86, 0.95, and 0.78, respectively; while the evaluation of MET lesions resulted in 0.91, 1.00, 1.00, 0.95, and 0.95 and 0.75, 0.90, 0.94, 0.85, and 0.82 using the 2D and 3D networks, respectively.

conclusionBoth 2D and 3D-DenseNets can differentiate FNH, HCC and MET with good accuracy when trained on hepatocyte-specific contrast-enhanced multi-sequence MRI volumes.

Indexed as

Carcinoma, HepatocellularDeep LearningLiver NeoplasmsContrast MediaHepatocytesHumansMagnetic Resonance ImagingRetrospective StudiesContrast MediaArtificial intelligenceDensely connected convolutional networkFocal nodular hyperplasiaHepatocellular carcinomaHepatocyte-specific contrastMulti-parametric magnetic resonance imaging

Identifiers

PMID34629814
PMCPMC8475009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.